Protein carbamylation predicts mortality in ESRD.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2013-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1681/ASN.2012030254PMID 23431074PMCID PMC3636787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiovascular disease in patients with chronic kidney disease

  2014cited by this paper
• Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study.

  2012cited by this paper
• The -174G/C variant of IL6 as risk factor for mortality and technique failure in a large cohort of peritoneal dialysis patients.

  2012cited by this paper
• Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.

  2012cited by this paper
• Advanced oxidation protein products and advanced glycation end products in children and adolescents with chronic renal insufficiency.

  2012cited by this paper
• Myeloperoxidase deficiency preserves vasomotor function in humans

  2011cited by this paper
• Is fetuin-A a mortality risk factor in dialysis patients or a mere risk marker? A Mendelian randomization approach.

  2011cited by this paper
• FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.

  2011cited by this paper
• Serum soluble CD36, assessed by a novel monoclonal antibody-based sandwich ELISA, predicts cardiovascular mortality in dialysis patients.

  2010cited by this paper
• Glycated Hemoglobin Predicts Mortality in Nondiabetic Patients Receiving Chronic Peritoneal Dialysis

  2010cited by this paper
• Chronic uremia stimulates LDL carbamylation and atherosclerosis.

  2010cited by this paper
• Anticitrulline antibodies can be caused by homocitrulline-containing proteins in rabbits.

  2010cited by this paper
• Review article: Biomarkers of clinical outcomes in advanced chronic kidney disease

  2009cited by this paper
• Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study.

  2009cited by this paper
• Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

  2008cited by this paper
• Protein carbamylation links inflammation, smoking, uremia and atherogenesis

  2007cited by this paper
• Serum myeloperoxidase and mortality in maintenance hemodialysis patients.

  2006cited by this paper
• Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease.

  2005cited by this paper
• Association between serum bicarbonate and death in hemodialysis patients: is it better to be acidotic or alkalotic?

  2005cited by this paper
• The Nutritional and Inflammatory Evaluation in Dialysis patients (NIED) study: overview of the NIED study and the role of dietitians.

  2005cited by this paper
• Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition.

  2004cited by this paper
• Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans

  2004cited by this paper
• Hypochlorous Acid, a Macrophage Product, Induces Endothelial Apoptosis and Tissue Factor Expression: Involvement of Myeloperoxidase-Mediated Oxidant in Plaque Erosion and Thrombogenesis

  2004cited by this paper
• Myeloperoxidase and plaque vulnerability.

  2004cited by this paper
• Accumulation of cyanide and thiocyanate in haemodialysis patients.

  2004cited by this paper
• Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

  2004cited by this paper
• Does residual renal function decline more rapidly in hemodialysis than in peritoneal dialysis? How good is the evidence?

  2004cited by this paper
• Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

  2003cited by this paper
• Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

  2003cited by this paper
• Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.

  2003cited by this paper
• Cardiovascular Mortality in End-Stage Renal Disease

  2003cited by this paper
• Diagnostic value of CRP and Lp(a) in coronary heart disease

  2002cited by this paper
• Myeloperoxidase Functions as a Major Enzymatic Catalyst for Initiation of Lipid Peroxidation at Sites of Inflammation*

  2002cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

  2002cited by this paper
• The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia.

  2002cited by this paper
• A Tale of Two Controversies

  2002cited by this paper
• Near infra-red interactance for longitudinal assessment of nutrition in dialysis patients.

  2001cited by this paper
• Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients.

  2001cited by this paper
• Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes.

  2001cited by this paper
• Uremic Toxicity: Urea and Beyond

  2001cited by this paper
• Carbamoylation of amino acids and proteins in uremia.

  2001cited by this paper
• Premature cardiovascular disease in chronic renal failure.

  2000cited by this paper
• Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species.

  2000cited by this paper
• Nitric oxide modulates the catalytic activity of myeloperoxidase.

  2000cited by this paper
• A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients.

  2000cited by this paper
• Epidemiology of cardiovascular disease in chronic renal disease

  2000cited by this paper
• Nitric Oxide Modulates the Catalytic Activity of Myeloperoxidase*

  2000cited by this paper
• Impaired Biological Activity of Erythropoietin by Cyanate Carbamylation

  2000cited by this paper
• CYANATE AS A HEMOLYTIC FACTOR

  2000cited by this paper
• The clinical epidemiology of cardiac disease in chronic renal failure.

  1999cited by this paper
• Clinical Subtypes of Alzheimer’s Disease

  1998cited by this paper
• "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc.

  1998cited by this paper
• Cardiovascular disease and mortality in ESRD.

  1998cited by this paper
• Epidemiology of cardiovascular disease in chronic renal disease.

  1998cited by this paper
• [Assessment of nutrition in dialysis patients and chronic uremic patients].

  1997cited by this paper
• Outcome and risk factors of ischemic heart disease in chronic uremia.

  1996cited by this paper
• Factors determining hemoglobin carbamylation in renal failure.

  1995cited by this paper
• Decreased clearance of uraemic and mildly carbamylated low‐density lipoprotein

  1994cited by this paper
• Urea-derived cyanate forms epsilon-amino-carbamoyl-lysine (homocitrulline) in leukocyte proteins in patients with end-stage renal disease on peritoneal dialysis.

  1994cited by this paper
• Gel isoelectric focusing for following the successive carbamylations of amino groups in chymotrypsinogen A.

  1971cited by this paper
• Reactions of the Cyanate Present in Aqueous Urea with Amino Acids and Proteins

  1960cited by this paper
• Original Report: Patient-oriented, Translational Research Soluble P-selectin Levels Are Associated with Cardiovascular Mortality and Sudden Cardiac Death in Male Dialysis Patients

  year unknowncited by this paper
• Nephrology Dialysis Transplantation near Infra-red Interactance for Nutritional Assessment of Dialysis Patients

  year unknowncited by this paper
• Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease and cardiac failure. Semin Dial 2003

  year unknowncited by this paper

• Guanidinylation compromises the anti-inflammatory and anti-oxidative properties of apolipoprotein A-I in chronic kidney disease progression.

  2025cites this paper
• Intergenerational Associations of Hypertensive Disorders of Pregnancy With Offspring Metabolomics: A Systematic Review

  2025cites this paper
• Lysine: Sources, Metabolism, Physiological Importance, and Use as a Supplement

  2025cites this paper
• Protein carbamylation is associated with increased mortality and CKD progression in patients with CKD: results from the EQUAL study

  2025cites this paper
• Homocitrulline Is Associated with Cardiovascular Outcomes in Nondialysis Patients with CKD

  2025cites this paper
• Post-translational modifications in kidney diseases and associated cardiovascular risk

  2024cites this paper
• Mediterranean Diet Pattern: Potential Impact on the Different Altered Pathways Related to Cardiovascular Risk in Advanced Chronic Kidney Disease

  2024cites this paper
• Comparative CKD risk prediction using homocitrulline and carbamylated albumin: two circulating markers of protein carbamylation

  2024cites this paper
• Protein Carbamylation and the Risk of ESKD in Patients with CKD

  2023cites this paper
• Gut Microbiota and the Ways to Correct it in Chronic Kidney Disease

  2023cites this paper
• Comparison of homocitrulline and carbamylated albumin as biomarkers of carbamylation reactions in hemodialyzed patients

  2023cites this paper
• What is the role of the neutrophil extracellular traps in the cardiovascular disease burden associated with hemodialysis bioincompatibility?

  2023cites this paper
• The Microbiome and Protein Carbamylation: Potential Targets for Protein-Restricted Diets Supplemented with Ketoanalogues in Predialysis Chronic Kidney Disease

  2023cites this paper
• Measurement of Homocitrulline, A Carbamylation‐derived Product, in Serum and Tissues by LC‐MS/MS

  2023cites this paper
• Renal insufficiency and chronic kidney disease - Promotor or consequence of pathological post-translational modifications.

  2022cites this paper
• Strategies for optimizing urea removal to enable portable kidney dialysis: A reappraisal.

  2022cites this paper
• The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aorta

  2022cites this paper
• Avenues for post-translational protein modification prevention and therapy.

  2022cites this paper
• Critical Appraisal of Limitations in the Current Definition/Classification of Uremic Toxins

  2022cites this paper
• Metabolite profiling of CKD progression in the chronic renal insufficiency cohort study

  2022cites this paper
• Carbamylation of Integrin αIIbβ3: The Mechanistic Link to Platelet Dysfunction in ESKD

  2022influential citation
• Metabolomic profiles to explore biomarkers of severe sarcopenia in older men: A pilot study.

  2022cites this paper
• Carbamylated Proteins in Renal Disease: Aggravating Factors or Just Biomarkers?

  2022cites this paper
• Physiological Mechanisms of Hypertension and Cardiovascular Disease in End-Stage Kidney Disease

  2022cites this paper
• Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations

  2021cites this paper
• New clinical evidences for urea toxicity.

  2021cites this paper
• [The value of a low-protein diet and ketoanalogues of essential amino acids in the сontrol of protein carbamylation and toxic effects of urea in chronic kidney disease].

  2021cites this paper
• Protein carbamylation and chronic kidney disease progression in the Chronic Renal Insufficiency Cohort Study

  2021influential citation
• Carbamylation of elastic fibers is a molecular substratum of aortic stiffness

  2021cites this paper
• High-Density Lipoproteins in Kidney Disease

  2021cites this paper
• Editorial: a call for a better understanding of the role of dietary amino acids and posttranslational protein modifications of microbiome in the progression of CKD.

  2021cites this paper
• Arterial Remodelling in Chronic Kidney Disease: Impact of Uraemic Toxins and New Pharmacological Approaches

  2021cites this paper
• Carbamylated HDL and Mortality Outcomes in Type 2 Diabetes

  2021cites this paper
• Effect of Sevelamer and Nicotinamide on Albumin Carbamylation in Patients with End-Stage Kidney Disease

  2021cites this paper
• An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure

  2020cites this paper
• Effect of Different Hemodialysis Methods on Microbiota in Uremic Patients

  2020influential citation
• Circulating uromodulin inhibits vascular calcification by interfering with pro-inflammatory cytokine signaling.

  2020cites this paper
• Proatherogenic importance of carbamylation-induced protein damage and type 2 diabetes mellitus: A systematic review.

  2020cites this paper
• Carbamylated Lipoproteins and Progression of Diabetic Kidney Disease.

  2020cites this paper
• Protein carbamylation and chronic kidney disease progression in the Chronic Renal Insufficiency Cohort Study.

  2020cites this paper
• Association of carbamylated high-density lipoprotein with coronary artery disease in type 2 diabetes mellitus: carbamylated high-density lipoprotein of patients promotes monocyte adhesion

  2020cites this paper
• Deletion of bone marrow myeloperoxidase attenuates chronic kidney disease accelerated atherosclerosis

  2020cites this paper
• Cerebro‐renal interaction and stroke

  2020cites this paper
• Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease

  2020cites this paper
• High concentrations of atmospheric isocyanic acid (HNCO) produced from secondary sources in China.

  2020cites this paper
• The effects of mutation and modification on the structure and stability of human lysozyme: A molecular link between carbamylation and atherosclerosis.

  2020cites this paper
• Immune Dysfunction in Uremia 2020

  2020cites this paper
• Post-translational modification-derived products are associated with frailty status in elderly subjects

  2019cites this paper
• A review on remediation of cyanide containing industrial wastes using biological systems with special reference to enzymatic degradation

  2019cites this paper
• Very Low Protein Diet for Patients with Chronic Kidney Disease: Recent Insights

  2019cites this paper
• Lipid-modifying therapy in chronic kidney disease: Pathophysiological and clinical considerations.

  2019cites this paper
• Nonenzymatic Posttranslational Protein Modifications: Mechanism and Associated Disease Pathologies

  2019cites this paper
• Ketoacid Analogues Supplementation in Chronic Kidney Disease and Future Perspectives

  2019cites this paper
• The Fate of Isocyanic Acid (HNCO): Investigation into Aqueous Phase Chemistry of HNCO

  2019cites this paper
• Blood urea nitrogen is independently associated with renal outcomes in Japanese patients with stage 3–5 chronic kidney disease: a prospective observational study

  2019cites this paper
• The Role of Nonenzymatic Post-translational Protein Modifications in Uremic Vascular Calcification.

  2019cites this paper
• Isocyanic acid (HNCO) and its fate in the atmosphere: a review.

  2019cites this paper
• The Pathophysiology of Uremia

  2019cites this paper
• Protein Carbamylation in Chronic Kidney Disease and Dialysis.

  2018cites this paper
• Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism

  2018cites this paper
• Full Reviews Urea and chronic kidney disease: the comeback of the century? (in uraemia research)

  2018influential citation
• Tolvaptan promotes urinary excretion of sodium and urea: a retrospective cohort study

  2018cites this paper
• Protein carbamylation exacerbates vascular calcification.

  2018cites this paper
• Protein Carbamylation: Chemistry, Pathophysiological Involvement, and Biomarkers.

  2018cites this paper
• The Role of Gut Microbiota and Diet on Uremic Retention Solutes Production in the Context of Chronic Kidney Disease

  2018cites this paper
• Cyanate improves insulin sensitivity and hepatic steatosis in normal and high fat-fed mice: Anorexic and antioxidative effects.

  2018cites this paper
• Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease–accelerated atherosclerosis

  2018cites this paper
• Nutritional therapy reduces protein carbamylation through urea lowering in chronic kidney disease

  2018cites this paper
• Protein Carbamylation in Peritoneal Dialysis and the Effect of Low Glucose Plus Amino Acid Solutions

  2018cites this paper
• Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update

  2018cites this paper
• PON-1 carbamylation is enhanced in HDL of uremia patients

  2018influential citation
• Urea and chronic kidney disease: the comeback of the century? (in uraemia research)

  2018cites this paper
• Gut Microbiota and Cardiovascular Uremic Toxicities

  2018cites this paper
• Measurement of Homocitrulline, A Carbamylation‐derived Product, in Serum and Tissues by LC‐MS/MS

  2018cites this paper
• Protein carbamylation in end stage renal disease: is there a mortality effect?

  2018cites this paper
• Increased electronegativity of high-density lipoprotein in uremia patients impairs its functional properties and is associated with the risk of coronary artery disease.

  2018cites this paper
• Kidney as modulator and target of “good/bad” HDL

  2018cites this paper
• Hydroxyhomocitrulline Is a Collagen-Specific Carbamylation Mark that Affects Cross-link Formation.

  2017cites this paper
• Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden?

  2017cites this paper
• Carbamylation is a competitor of glycation for protein modification in vivo.

  2017cites this paper
• The Cardiovascular Burden in End-Stage Renal Disease.

  2017cites this paper
• ApoB and apoM – New aspects of lipoprotein biology in uremia‐induced atherosclerosis

  2017cites this paper
• Mechanisms and consequences of carbamoylation

  2017cites this paper
• Binding of bromocresol green and bromocresol purple to albumin in hemodialysis patients

  2017cites this paper
• Urea-induced ROS accelerate senescence in endothelial progenitor cells.

  2017cites this paper
• Urea- and Creatinine-Based Parameters in the Optical Monitoring of Dialysis: The Case of Lean Body Mass and Urea Rebound Assessment. Uureal ja kreatiniinil põhinevad parameetrid neeruasendusravi optilises monitooringus: patsiendi lihasmassi ja uurea tagasilöögi efekti hindamine

  2017cites this paper
• Metabolites related to renal function, immune activation, and carbamylation are associated with muscle composition in older adults

  2017cites this paper
• Increased carbamylation level of high-density lipoprotein in 1 end-stage renal disease: carbamylated-HDL attenuated endothelial 2 cell function

  2016cites this paper
• Increased carbamylation level of HDL in end-stage renal disease: carbamylated-HDL attenuated endothelial cell function.

  2016cites this paper
• Homocitrulline: a new marker for differentiating acute from chronic renal failure

  2016cites this paper
• Carbamylated Low-Density Lipoprotein (cLDL)-Mediated Induction of Autophagy and Its Role in Endothelial Cell Injury

  2016cites this paper
• Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis.

  2016influential citation
• Urea, a true uremic toxin: the empire strikes back.

  2016cites this paper
• Urea impairs β cell glycolysis and insulin secretion in chronic kidney disease.

  2016cites this paper
• Eosinophil Peroxidase Catalyzed Protein Carbamylation Participates in Asthma*

  2016cites this paper
• Reconsidering the Lack of Urea Toxicity in Dialysis Patients

  2016cites this paper
• Homocitrulline as marker of protein carbamylation in hemodialyzed patients.

  2016cites this paper
• Reduction of carbamylated albumin by extended hemodialysis

  2016cites this paper
• Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease.

  2016cites this paper
• HEMO Revisited: Why Kt/Vurea Only Tells Part of the Story.

  2016cites this paper